Human Microbiome Market, By Product, By Diseases, By Type, By Route of Administration, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Description

REPORT HIGHLIGHT

Human microbiome market size was valued at US$ 821.90 Million in 2024, expanding at a CAGR of 31.20% from 2025 to 2032.

The human microbiome refers to the diverse community of microorganisms, including bacteria, viruses, fungi, and other microbes, that inhabit various parts of the human body such as the gut, skin, mouth, and respiratory tract. These microorganisms play a vital role in maintaining health by aiding digestion, supporting the immune system, and protecting against pathogens. Disruptions in the microbiome balance are linked to various diseases, including obesity, diabetes, and autoimmune disorders.

Human Microbiome Market- Market Dynamics

Increasing prevalence of chronic diseases to propel market demand

The increasing incidence of chronic conditions such as obesity, diabetes, and inflammatory bowel disease (IBD) is propelling the demand for microbiome-based therapies. According to the World Obesity Atlas 2023, 38% of the global population, approximately 3.12 billion people are overweight or obese. In addition, substantial government funding is accelerating advancements in microbiome science, which is driving the growth of the global human microbiome market. However, high cost of R&D and stringent regulatory frameworks may hamper the market growth during the forecast period. On the contrary, the growing emphasis on personalized healthcare presents opportunities for microbiome-based diagnostics and treatments tailored to individual microbiota profiles.

Human Microbiome Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 31.20% over the forecast period (2025-2032)

Based on Product segmentation, probiotics was predicted to show maximum market share in the year 2024

Based on Diseases segmentation, gastrointestinal was the leading Diseases in 2024

Based on Type segmentation, live biotherapeutic products (LBP) was the leading Type in 2024

On the basis of region, North America was the leading revenue generator in 2024

Human Microbiome Market- Segmentation Analysis:

The Global Human Microbiome Market is segmented on the basis of Product, Diseases, Type, Route of Administration, End-user, and Region.

The market is divided into four categories based on Product: prebiotics, probiotics, drugs, and sybnbiotics. The probiotics segment is anticipated to hold the largest market share in the global human microbiome market during the forecast period. This dominance is attributed to increasing consumer awareness of the benefits of probiotics for gut health, immunity, and overall wellness.

The market is divided into four categories based on Diseases: gastrointestinal diseases, infectious diseases, endocrine & metabolic disorders, and other diseases. Among these, the gastrointestinal diseases segment is anticipated to hold the largest market share in the market. This dominance is attributed to the high prevalence of gastrointestinal conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), celiac disease, and gastroesophageal reflux disease (GERD).

Human Microbiome Market- Geographical Insights

The North America region holds the largest share of the global human microbiome market. This dominance is attributed to a well-established healthcare infrastructure, significant investments in microbiome research, and a high prevalence of chronic diseases. Besides, the Asia-Pacific region is projected to experience the fastest growth in the human microbiome market during the forecast period. This rapid expansion is driven by increasing awareness of microbiome health, rising demand for personalized medicine, and advancements in sequencing technologies.

Human Microbiome Market- Competitive Landscape:

Rising interest in personalized medicine and microbiome-based therapies is driving intense competition among companies in this emerging field. Industry participants are focusing on strategic collaborations with research institutions and healthcare providers to accelerate product development. Many are investing heavily in R&D to discover novel microbiome-based diagnostics and therapeutics. Additionally, companies are securing patents and engaging in licensing agreements to strengthen their pipelines. Expansion into untapped regions and the development of consumer-targeted microbiome products also form key competitive strategies.

Recent Developments:

In February 2025, Seres Therapeutics launched SER-109, the first FDA-approved microbiome therapy in the U.S., designed to treat recurrent C. difficile infection by restoring gut microbiota using live bacterial spores.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HUMAN MICROBIOME MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

ENTEROME
Pendulum
DuPont
Yakult U.S.A. Inc.
Metabiomics
Vedanta Biosciences, Inc.
Optibiotix Health plc
Microbiome Therapeutics Innovation Group
BioHM Health
Osel, Inc.
Seres Therapeutics
Infinant Health Inc.
Merck & Co., Inc.
Theriva Biologics
Qualigen Therapeutics, Inc.
Synlogic
Symbiotix, LLC
Resbiotic
Symberix, Inc.
Exegi Pharma Inc.
Seed Health Inc.
Biogaia AB
BiomeBank
Ferring Pharmaceuticals
Others

GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Prebiotics
Drugs
Synbiotics

GLOBAL HUMAN MICROBIOME MARKET, BY DISEASES- MARKET ANALYSIS, 2019 - 2032

Gastrointestinal Diseases
Infectious Diseases
Endocrine & Metabolic Disorders
Other Diseases

GLOBAL HUMAN MICROBIOME MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Live Biotherapeutic Products (LBP)
Bacterial Consortia Transplantation (BCT) / Fecal Microbiota Transplantation (FMT)
Other Microbiome Types

GLOBAL HUMAN MICROBIOME MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

Rectal
Oral

GLOBAL HUMAN MICROBIOME MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Long-term Care Facilities
Hospitals & Clinics
Others

GLOBAL HUMAN MICROBIOME MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV5432

1. Human Microbiome Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Human Microbiome Market Snippet by Product
- 2.1.2. Human Microbiome Market Snippet by Diseases
- 2.1.3. Human Microbiome Market Snippet by Type
- 2.1.4. Human Microbiome Market Snippet by Route of Administration
- 2.1.5. Human Microbiome Market Snippet by End User
- 2.1.6. Human Microbiome Market Snippet by Country
- 2.1.7. Human Microbiome Market Snippet by Region
2.2. Competitive Insights

3. Human Microbiome Key Market Trends

3.1. Human Microbiome Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Human Microbiome Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Human Microbiome Market Opportunities
3.4. Human Microbiome Market Future Trends

4. Human Microbiome Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Human Microbiome Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Human Microbiome Market Landscape

6.1. Human Microbiome Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Human Microbiome Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
- 7.1.2. Probiotics
- 7.1.3. Drugs
- 7.1.4. Synbiotics

8. Human Microbiome Market - By Diseases

8.1. Overview
- 8.1.1. Segment Share Analysis, By Diseases, 2024 & 2032 (%)
- 8.1.2. Gastrointestinal Diseases
- 8.1.3. Infectious Diseases
- 8.1.4. Endocrine & Metabolic Disorders
- 8.1.5. Other Diseases

9. Human Microbiome Market - By Type

9.1. Overview
- 9.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
- 9.1.2. Live Biotherapeutic Products (LBP)
- 9.1.3. Bacterial Consortia Transplantation (BCT) / Fecal Microbiota Transplantation (FMT)
- 9.1.4. Other Microbiome Types

10. Human Microbiome Market - By Route of Administration

10.1. Overview
- 10.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
- 10.1.2. Rectal
- 10.1.3. Oral

11. Human Microbiome Market - By End User

11.1. Overview
- 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 11.1.2. Long-term Care Facilities
- 11.1.3. Hospitals & Clinics
- 11.1.4. Others

12. Human Microbiome Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Human Microbiome Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Human Microbiome Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.18. Rest of Europe
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.18.4. Rest of the Europe Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.3.18.5. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.18.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Human Microbiome Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Human Microbiome Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Human Microbiome Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Diseases, 2019 - 2032 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Human Microbiome Industry

13.1. Competitive Dashboard
- 13.1.1. Competitive Benchmarking
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. ENTEROME
- 13.2.2. Pendulum
- 13.2.3. DuPont
- 13.2.4. Yakult U.S.A. Inc.
- 13.2.5. Metabiomics
- 13.2.6. Vedanta Biosciences, Inc.
- 13.2.7. Optibiotix Health plc
- 13.2.8. Microbiome Therapeutics Innovation Group
- 13.2.9. BioHM Health
- 13.2.10. Osel, Inc.
- 13.2.11. Seres Therapeutics
- 13.2.12. Infinant Health Inc.
- 13.2.13. Merck & Co., Inc.
- 13.2.14. Theriva Biologics
- 13.2.15. Qualigen Therapeutics, Inc.
- 13.2.16. Synlogic
- 13.2.17. Symbiotix, LLC
- 13.2.18. Resbiotic
- 13.2.19. Symberix, Inc.
- 13.2.20. Exegi Pharma Inc.
- 13.2.21. Seed Health Inc.
- 13.2.22. Biogaia AB
- 13.2.23. BiomeBank
- 13.2.24. Ferring Pharmaceuticals
- 13.2.25. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us